Wall Street Analysts Think KalVista Pharmaceuticals (KALV) Could Surge 117.1%: Read This Before Placing a Bet

KalVista Pharmaceuticals, Inc. (KALV) closed the last trading session at $15.56, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $33.78 indicates an 117.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $5.4. While the lowest estimate of $22.00 indicates a 41.4% increase from the current price level, the most opt ...